Key result
Premature CV mortality in Hainan rose ~24%, driven by ischemic heart disease and stroke.
Why the study?
Trends, population and geographic differences, and subtype-specific potential gains in life expectancy for premature mortality from cardiovascular and cerebrovascular diseases in Hainan Province during 2014–2024 required evaluation.
Observational
Yes
Premature cardiovascular mortality burden increased in Hainan Province from 2014 to 2024, driven primarily by ischaemic heart disease and ischaemic stroke, which together with haemorrhagic stroke accounted for 71.11% of total CVD-related years of life lost in 2024.
Answers are grounded in this paper and cite their sources.
Rising premature CVD mortality in Hainan signals prevention gaps; leaves open whether targeted strategies can reverse ischaemic trends.
Background. We examined premature mortality from cardiovascular and cerebrovascular diseases (CVDs) in Hainan Province during 2014–2024, including trends, population and geographic differences, and subtype-specific potential gains in life expectancy. Methods. Cause-of-death surveillance data were corrected for underreporting. Years of life lost (YLL) and age-standardised YLL rates quantified burden. Joinpoint regression assessed trends. Regional comparisons used Kruskal–Wallis tests with Holm correction; Global Moran’s I assessed spatial autocorrelation. Cause-deleted life tables estimated theoretical potential life expectancy gains. Results. CVD-related YLL increased from 304372.12 person-years in 2014 to 515851.41 person-years in 2024; the age-standardised YLL rate rose from 4240.12 to 5245.28 per 100000. In 2024, ischaemic heart disease, ischaemic stroke and haemorrhagic stroke accounted for 30.25%, 22.68% and 18.18% of total CVD-related YLL, respectively, or 71.11% combined. Ischaemic stroke showed the fastest increase in age-standardised YLL rate, with an average annual percent change of 7.91% (95% confidence interval: 6.15%–10.35%). Hypertensive diseases and ischaemic heart disease also increased significantly, whereas pulmonary heart disease and diseases of the pulmonary circulation declined. Except for rheumatic heart disease, age-standardised YLL rates were higher in males. Burden generally increased with age. The eastern region had a descriptively lower burden than the central and western regions; no regional comparison remained significant after Holm correction, and no significant global spatial autocorrelation was detected. In 2024, life expectancy at birth was 81.32 years. Eliminating ischaemic heart disease and ischaemic stroke deaths yielded the largest theoretical gains, at 1.87 and 1.54 years, respectively. Conclusions. Premature cardiovascular mortality burden increased in Hainan. Ischaemic heart disease and ischaemic stroke were the main contributors to burden and life expectancy loss. Prevention should prioritise these subtypes, males and older adults, with local planning informed by descriptive burden patterns. Contributions to the literature Long-term mortality surveillance adds local evidence on how the burden of individual cardiovascular diseases has changed in Hainan, beyond studies of overall disease burden. Combining years of life lost with theoretical gains in life expectancy provides complementary information for population health planning. Comparisons by disease subtype, sex and age help identify prevention priorities; geographic patterns can inform local planning while acknowledging statistical uncertainty.
No takes yet. Share an insight, caveat, or question.
Lv et al. (2026) conducted an observational in Cardiovascular and cerebrovascular diseases (CVDs). Cardiovascular and cerebrovascular disease subtypes (2024 vs 2014 temporal trend) vs. 2014 baseline surveillance rates was evaluated on Age-standardised years of life lost (YLL) rate per 100,000 for total CVDs (23.71% increase). Premature cardiovascular mortality in Hainan rose by 23.71% in age-standardised YLL rate from 2014 to 2024, driven by ischaemic heart disease and ischaemic stroke.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: